Approval · Notice of Compliance 26535 · 2021
ZOPICLONE TABLETS: Notice of Compliance 26535
Issued August 27, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26535
- Date
- August 27, 2021
- Company
- Strides Pharma Canada IncVaughan, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
- Canadian reference product
- IMOVANE (Sanofi-Aventis Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZOPICLONE TABLETS | 02492407 | Cancelled Post Market |
| ZOPICLONE TABLETS | 02425874 | Cancelled Post Market |
| ZOPICLONE TABLETS | 02425882 | Cancelled Post Market |